Recommendations for probiotic use

2011 update

Martin H. Floch, W. Allan Walker, Karen Madsen, Mary Ellen Sanders, George T. Macfarlane, Harry J. Flint, Levinus A. Dieleman, Yehuda Ringel, Stefano Guandalini, Ciaran P. Kelly, Lawrence J. Brandt

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

This study describes the consensus opinion of the participants of the third Yale Workshop on probiotic use. There were 10 experts participating. The recommendations update those of the first 2 meetings that were published in 2005 and 2008. The workshop presentations and papers in this supplement relate to the involvement of normal microbiota involved in intestinal microecology, how the microbes interact with the intestine to affect our immunologic responses, the stability and natural history of probiotic organisms, and the role of the intestinal microbatome with regard to affecting cardiac risk factors and obesity. Recommendations for the use of probiotics in necrotizing enterocolitis, childhood diarrhea, inflammatory bowel disease, irritable bowel syndrome, and Clostridium difficile diarrhea are reviewed. As in previous publications, the recommendations are given as A, B, or C ratings. The recent positive experiences with bacteriotherapy (fecal microbiome transplant) are also discussed in detail and a positive recommendation is made for use in severe resistant C. difficile diarrhea.

Original languageEnglish
Pages (from-to)S168-S171
Number of pages4
JournalJournal of Clinical Gastroenterology
Volume45
DOIs
Publication statusPublished - Nov 2011

Keywords

  • probiotics
  • recommendations
  • diarrhea
  • irritable-bowel-syndrome
  • placebo-controlled trial
  • antibiotic-assoiated diarrhea
  • double-blind
  • ulcerative-colitis
  • Crohns-disease
  • maintaining remission
  • maintenance treatment
  • Escherichia-coli
  • lactobacillus

Cite this

Floch, M. H., Walker, W. A., Madsen, K., Sanders, M. E., Macfarlane, G. T., Flint, H. J., ... Brandt, L. J. (2011). Recommendations for probiotic use: 2011 update. Journal of Clinical Gastroenterology, 45, S168-S171. https://doi.org/10.1097/MCG.0b013e318230928b

Recommendations for probiotic use : 2011 update. / Floch, Martin H.; Walker, W. Allan; Madsen, Karen; Sanders, Mary Ellen; Macfarlane, George T.; Flint, Harry J.; Dieleman, Levinus A.; Ringel, Yehuda; Guandalini, Stefano; Kelly, Ciaran P.; Brandt, Lawrence J.

In: Journal of Clinical Gastroenterology, Vol. 45, 11.2011, p. S168-S171.

Research output: Contribution to journalArticle

Floch, MH, Walker, WA, Madsen, K, Sanders, ME, Macfarlane, GT, Flint, HJ, Dieleman, LA, Ringel, Y, Guandalini, S, Kelly, CP & Brandt, LJ 2011, 'Recommendations for probiotic use: 2011 update', Journal of Clinical Gastroenterology, vol. 45, pp. S168-S171. https://doi.org/10.1097/MCG.0b013e318230928b
Floch MH, Walker WA, Madsen K, Sanders ME, Macfarlane GT, Flint HJ et al. Recommendations for probiotic use: 2011 update. Journal of Clinical Gastroenterology. 2011 Nov;45:S168-S171. https://doi.org/10.1097/MCG.0b013e318230928b
Floch, Martin H. ; Walker, W. Allan ; Madsen, Karen ; Sanders, Mary Ellen ; Macfarlane, George T. ; Flint, Harry J. ; Dieleman, Levinus A. ; Ringel, Yehuda ; Guandalini, Stefano ; Kelly, Ciaran P. ; Brandt, Lawrence J. / Recommendations for probiotic use : 2011 update. In: Journal of Clinical Gastroenterology. 2011 ; Vol. 45. pp. S168-S171.
@article{77ce1b469c6c44fd8ce845ad08138dc6,
title = "Recommendations for probiotic use: 2011 update",
abstract = "This study describes the consensus opinion of the participants of the third Yale Workshop on probiotic use. There were 10 experts participating. The recommendations update those of the first 2 meetings that were published in 2005 and 2008. The workshop presentations and papers in this supplement relate to the involvement of normal microbiota involved in intestinal microecology, how the microbes interact with the intestine to affect our immunologic responses, the stability and natural history of probiotic organisms, and the role of the intestinal microbatome with regard to affecting cardiac risk factors and obesity. Recommendations for the use of probiotics in necrotizing enterocolitis, childhood diarrhea, inflammatory bowel disease, irritable bowel syndrome, and Clostridium difficile diarrhea are reviewed. As in previous publications, the recommendations are given as A, B, or C ratings. The recent positive experiences with bacteriotherapy (fecal microbiome transplant) are also discussed in detail and a positive recommendation is made for use in severe resistant C. difficile diarrhea.",
keywords = "probiotics, recommendations, diarrhea, irritable-bowel-syndrome, placebo-controlled trial, antibiotic-assoiated diarrhea, double-blind, ulcerative-colitis, Crohns-disease, maintaining remission, maintenance treatment, Escherichia-coli, lactobacillus",
author = "Floch, {Martin H.} and Walker, {W. Allan} and Karen Madsen and Sanders, {Mary Ellen} and Macfarlane, {George T.} and Flint, {Harry J.} and Dieleman, {Levinus A.} and Yehuda Ringel and Stefano Guandalini and Kelly, {Ciaran P.} and Brandt, {Lawrence J.}",
year = "2011",
month = "11",
doi = "10.1097/MCG.0b013e318230928b",
language = "English",
volume = "45",
pages = "S168--S171",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Recommendations for probiotic use

T2 - 2011 update

AU - Floch, Martin H.

AU - Walker, W. Allan

AU - Madsen, Karen

AU - Sanders, Mary Ellen

AU - Macfarlane, George T.

AU - Flint, Harry J.

AU - Dieleman, Levinus A.

AU - Ringel, Yehuda

AU - Guandalini, Stefano

AU - Kelly, Ciaran P.

AU - Brandt, Lawrence J.

PY - 2011/11

Y1 - 2011/11

N2 - This study describes the consensus opinion of the participants of the third Yale Workshop on probiotic use. There were 10 experts participating. The recommendations update those of the first 2 meetings that were published in 2005 and 2008. The workshop presentations and papers in this supplement relate to the involvement of normal microbiota involved in intestinal microecology, how the microbes interact with the intestine to affect our immunologic responses, the stability and natural history of probiotic organisms, and the role of the intestinal microbatome with regard to affecting cardiac risk factors and obesity. Recommendations for the use of probiotics in necrotizing enterocolitis, childhood diarrhea, inflammatory bowel disease, irritable bowel syndrome, and Clostridium difficile diarrhea are reviewed. As in previous publications, the recommendations are given as A, B, or C ratings. The recent positive experiences with bacteriotherapy (fecal microbiome transplant) are also discussed in detail and a positive recommendation is made for use in severe resistant C. difficile diarrhea.

AB - This study describes the consensus opinion of the participants of the third Yale Workshop on probiotic use. There were 10 experts participating. The recommendations update those of the first 2 meetings that were published in 2005 and 2008. The workshop presentations and papers in this supplement relate to the involvement of normal microbiota involved in intestinal microecology, how the microbes interact with the intestine to affect our immunologic responses, the stability and natural history of probiotic organisms, and the role of the intestinal microbatome with regard to affecting cardiac risk factors and obesity. Recommendations for the use of probiotics in necrotizing enterocolitis, childhood diarrhea, inflammatory bowel disease, irritable bowel syndrome, and Clostridium difficile diarrhea are reviewed. As in previous publications, the recommendations are given as A, B, or C ratings. The recent positive experiences with bacteriotherapy (fecal microbiome transplant) are also discussed in detail and a positive recommendation is made for use in severe resistant C. difficile diarrhea.

KW - probiotics

KW - recommendations

KW - diarrhea

KW - irritable-bowel-syndrome

KW - placebo-controlled trial

KW - antibiotic-assoiated diarrhea

KW - double-blind

KW - ulcerative-colitis

KW - Crohns-disease

KW - maintaining remission

KW - maintenance treatment

KW - Escherichia-coli

KW - lactobacillus

U2 - 10.1097/MCG.0b013e318230928b

DO - 10.1097/MCG.0b013e318230928b

M3 - Article

VL - 45

SP - S168-S171

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

ER -